|  | Moderators 08.00 08.00
 08.10
 |  |  | N. Cheshire, T. Kolbel News of imaging developments
 The future of 3D ultrasound: why is it necessary? A. Long
 4D MRI: useful tool or new gadget? R. Clough
 | 
|  | 08.20 
 |  |  | Controversy: where is the best place for endovascular surgery | 
|  | 08.20 |  |  | OR with modern C arm and softwares are the best place, S. Haulon | 
|  | 08.30 |  |  | A Hybrid suite is a much better place, H. Kobeiter | 
|  | 08.40 |  |  | Simulation rehearsal before endovascular interventions: why it improves our practice, I. Van Herzeele
  | 
|  | 08.50 |  |  | Discussion | 
|  | 08.55 |  |  | Newest technology for EVAR: devices presentations and results 
 | 
|  | 08.55 |  |  | Cook Low Profile, S. Haulon  | 
|  | 09.05 |  |  | Medtronic Endurant, H. Verhagen | 
|  | 09.15 |  |  | GoreC3, E.Verhoeven  | 
|  | 09.25 |  |  | Endologix Nellix, E. Ducasse  | 
|  | 09.35 |  |  | Endologix AFX, J-P. De Vries | 
|  | 09.45 |  |  | Vascutek Anaconda, D. Midy  | 
|  | 09.55 |  |  | Trivascular Ovation, N. Mangialardi  | 
|  | 10.00 |  |  | Discussion | 
|  |  |  |  |  | 
|  | 10.05 |  |  | Break in the exhibition hall - Sponsored by  | 
|  |  |  |  |  | 
|  | Moderators |  |  | E. Allaire, M. Malina, R. Chaer | 
|  | 10.35
 |  |  | Session kindly sponsored by  Abdominal aneurysms
 Controversy: AAA Duplex measurement internal or external diameter
 
 | 
|  | 10.35 |  |  | External diameter is the rule: we must keep it this way? A. Long  | 
|  | 10.45 |  |  | Internal diameter must be the new rule! T. Hartshorne  | 
|  | 10.55 |  |  | Discussion | 
|  | 11.05 |  |  | How to keep a small aneurysm small, E. Allaire  | 
|  | 11.15 |  |  | EVAR in out clinic patients: is it feasible and safe? M. L. Lachat | 
|  | 11.25 |  |  | Discussion | 
| 
 
 | 11.30 11.30
 
 |  |  | Dealing with EVAR problems Type II endoleaks They are not benign, S. El Batti
 
 | 
|  | 11.40 |  |  | What are the best means to detect them: CT scan, Duplex or MRI, F. L. Moll  | 
|  | 11.50 |  |  | Discussion | 
|  | 12.00 
 |  |  | Controversy: pre emptive treatment of type II endoleak | 
|  | 12.00 |  |  | Coil embolisation is the most efficient way, D. Fabre  | 
|  | 12.08 |  |  | Thrombin injection is much better, A. Cardon  | 
|  | 12.16 |  |  | Type II endoleak: the trans vena cava approach, P. Bergeron | 
|  | 12.24 |  |  | Discussion | 
|  |  |  |  |  | 
|  | 12.30 |  |  | Lunch in the exhibition hall | 
|  |  |  |  |  | 
|  | 13.15 |  |  | Symposium  | 
|  | 13.30 
 |  |  | lndustry symposia      
 | 
|  | Moderators 14.30
 14.30
 
 |  |  | F. Moll, Y. Alimi, J. Busquet, J. Brunkwall EVAR follow up: answers to uncertainties
 When can we stop following patients with EVAR? H. Verhagen
 | 
|  | 14.40 |  |  | Does reintervention influence the late results of EVAR? F. Verzini  | 
|  | 14.50 |  |  | Inflammatory response after EVAR: causes and clinical implication, C. D. Liapis  | 
|  | 15.00 |  |  | What to do when EVAR becomes infected, C. Setacci  | 
|  | 15.10 |  |  | Ruptures following EVAR: can we prevent them? R.M. Greenhalgh | 
|  | 15.20 |  |  | Discussion | 
|  | 15.25 |  |  | Occlusive diseases: aorto-iliac and visceral arteries | 
|  | 15.25 |  |  | Endovascular repair of totally occluded infra renal aorta and iliac arteries, N. Mangialardi  | 
|  | 15.35 |  |  | Cyclists with Iliac endofibrosis: how to help them to win the Tour de France? P. Feugier  | 
|  | 15.45 |  |  | Chronic visceral arteries occlusive diseases: when to choose open when endo, P. Gloviczki  | 
|  | 15.55 |  |  | Discussion | 
|  |  |  |  |  | 
|  |  |  |  |  | 
|  | Moderators |  |  | L. Canaud, M. Bosiers, P. Desgranges | 
|  |  |  |  | Session kindly sponsored by  | 
|  | 16.30 |  |  | Do the newest grafts achieve comparable results to saphenous vein bypass? | 
|  | 16.30 |  |  | The fusion grafts, H-H.Eckstein | 
|  | 16.40 |  |  | The heparin-bonded ePTFe grafts, C. Pratesi  | 
|  | 16.50 |  |  | Controversy: bare stents or covered stents in the SFA? | 
|  | 16.50 |  |  | Bare metal stents fulfill their goals, A. Sala Tenna  | 
|  | 17.00 |  |  | Covered stents provide better results, M. Bosiers  
 | 
|  | 17.10 |  |  | Newest technology in the SFA: the future is now | 
|  | 17.10 |  |  | The latest results with Drug Eluting Stents, J. Tessarek  | 
|  | 17.20 |  |  | Drug eluting balloon, J-P. De Vries | 
|  | 17.30 |  |  | In-stent restenosis: hopes from new therapy, Y. Gouëffic  | 
|  | 17.40 |  |  | Tibial arteries | 
|  | 17.40 |  |  | Technique for pedal access and pedalloop interventions, R. Ferraresi  | 
|  | 17.50 |  |  | Controversy: tibial arteries repair 
 | 
|  | 17.50 |  |  | Endovascular repair is not durable, R. Chaer  | 
|  | 18.00 |  |  | Those who know how to do it have no doubts, P. Schneider  | 
|  |  |  |  | Discussion | 
|  |  |  |  |  | 
|  | 18.20 |  |  | Honorary guest lecture: to build and run an hospital in Kabul, E. Cheysson 
 | 
|  | 18.35 |  |  | End of the sessions |